Compare · BON vs CGC
BON vs CGC
Side-by-side comparison of Bon Natural Life Limited (BON) and Canopy Growth Corporation (CGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BON and CGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- CGC is the larger of the two at $2.86B, about 293.4x BON ($9.8M).
- Over the past year, BON is down 21.3% and CGC is down 26.1% - BON leads by 4.8 points.
- CGC has hit the wire 6 times in the past 4 weeks while BON has been quiet.
- CGC has more recent analyst coverage (19 ratings vs 0 for BON).
- Company
- Bon Natural Life Limited
- Canopy Growth Corporation
- Price
- $1.17-2.92%
- $0.92-1.51%
- Market cap
- $9.8M
- $2.86B
- 1M return
- -8.98%
- -4.54%
- 1Y return
- -21.28%
- -26.07%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 0
- 6
- Recent ratings
- 0
- 19
Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Latest BON
- SEC Form 3 filed by new insider Zhixiang Gao
- SEC Form 3 filed by new insider Chen Jing Veronica
- SEC Form 3 filed by new insider Hu Yongwei
- SEC Form 3 filed by new insider Xue Yingchun
- SEC Form 3 filed by new insider Ma Xin
- SEC Form 3 filed by new insider Wenjuan Chen
- SEC Form 3 filed by new insider Liu Jing
- SEC Form 3 filed by new insider Gao Jianjun
- BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives
- SEC Form 6-K filed by Bon Natural Life Limited
Latest CGC
- Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference
- SEC Form PRE 14A filed by Canopy Growth Corporation
- Director Bayern Joseph sold $2,953 worth of shares (3,197 units at $0.92), decreasing direct ownership by 2% to 145,127 units (SEC Form 4) (withholding tax)
- Director Yanofsky Theresa sold $13,905 worth of shares (15,054 units at $0.92), decreasing direct ownership by 9% to 146,415 units (SEC Form 4) (withholding obligation)
- Director Atkins M Shan sold $2,953 worth of shares (3,197 units at $0.92), decreasing direct ownership by 2% to 146,517 units (SEC Form 4) to cover taxes
- Director Lazzarato David Angelo sold $20,944 worth of shares (22,674 units at $0.92), decreasing direct ownership by 10% to 211,859 units (SEC Form 4) to cover withholding tax
- Director Atkins M Shan was granted 108,324 shares, increasing direct ownership by 262% to 149,714 units (SEC Form 4)
- Director Lazzarato David Angelo was granted 162,485 shares, increasing direct ownership by 226% to 234,533 units (SEC Form 4)
- Director Bayern Joseph was granted 108,324 shares, increasing direct ownership by 271% to 148,324 units (SEC Form 4)
- Director Yanofsky Theresa was granted 108,324 shares, increasing direct ownership by 204% to 161,469 units (SEC Form 4)